The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Radiopharmaceutical Injector Market Research Report 2025
Synopsis
A radiopharmaceutical injector is a medical device used to administer radiopharmaceuticals to patients. Radiopharmaceuticals are drugs that contain radioactive isotopes, which emit gamma rays or positrons that can be detected by specialized imaging equipment. These drugs are used in nuclear medicine for diagnostic imaging and therapy.
The radiopharmaceutical injector is specifically designed to safely and accurately deliver these radioactive drugs into the patient's body. It ensures precise control over the injection process, including the injection rate, volume, and timing. This control is crucial to ensure optimal distribution of the radiopharmaceutical within the patient's body and accurate imaging or therapeutic results.
The global Radiopharmaceutical Injector market was valued at US$ 27 million in 2023 and is anticipated to reach US$ 46 million by 2030, witnessing a CAGR of 7.4% during the forecast period 2024-2030.
Global key players of Radiopharmaceutical Injector include Medrad, Inc.(Bayer), UNIVERSAL GIKEN and Comecer, etc. The top three players hold a share over 65%. Medrad, Inc.(Bayer) is the largest manufacturers of Radiopharmaceutical Injector in the world, has a share about 30%. Europe is the largest market, has a share about 35%. In terms of product type, PET Radioactive Drugs Injector is the largest segment, occupied for a share of 85%, and in terms of application, Hospitals and Clinics has a share about 80 percent.
This report aims to provide a comprehensive presentation of the global market for Radiopharmaceutical Injector, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radiopharmaceutical Injector.
Report Scope
The Radiopharmaceutical Injector market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Radiopharmaceutical Injector market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Radiopharmaceutical Injector manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medrad, Inc.(Bayer)
UNIVERSAL GIKEN
Comecer
Sumitomo Heavy Industries
Tema Sinergie
Lemer Pax
BQSV
Segment by Type
PET Radioactive Drugs Injector
PET and SPECT Radioactive Drugs Injector
Segment by Application
Hospitals and Clinics
R&D Institution
Consumption by Region
North America
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Radiopharmaceutical Injector manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Radiopharmaceutical Injector in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
A radiopharmaceutical injector is a medical device used to administer radiopharmaceuticals to patients. Radiopharmaceuticals are drugs that contain radioactive isotopes, which emit gamma rays or positrons that can be detected by specialized imaging equipment. These drugs are used in nuclear medicine for diagnostic imaging and therapy.
The radiopharmaceutical injector is specifically designed to safely and accurately deliver these radioactive drugs into the patient's body. It ensures precise control over the injection process, including the injection rate, volume, and timing. This control is crucial to ensure optimal distribution of the radiopharmaceutical within the patient's body and accurate imaging or therapeutic results.
The global Radiopharmaceutical Injector market was valued at US$ 27 million in 2023 and is anticipated to reach US$ 46 million by 2030, witnessing a CAGR of 7.4% during the forecast period 2024-2030.
Global key players of Radiopharmaceutical Injector include Medrad, Inc.(Bayer), UNIVERSAL GIKEN and Comecer, etc. The top three players hold a share over 65%. Medrad, Inc.(Bayer) is the largest manufacturers of Radiopharmaceutical Injector in the world, has a share about 30%. Europe is the largest market, has a share about 35%. In terms of product type, PET Radioactive Drugs Injector is the largest segment, occupied for a share of 85%, and in terms of application, Hospitals and Clinics has a share about 80 percent.
This report aims to provide a comprehensive presentation of the global market for Radiopharmaceutical Injector, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radiopharmaceutical Injector.
Report Scope
The Radiopharmaceutical Injector market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Radiopharmaceutical Injector market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Radiopharmaceutical Injector manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medrad, Inc.(Bayer)
UNIVERSAL GIKEN
Comecer
Sumitomo Heavy Industries
Tema Sinergie
Lemer Pax
BQSV
Segment by Type
PET Radioactive Drugs Injector
PET and SPECT Radioactive Drugs Injector
Segment by Application
Hospitals and Clinics
R&D Institution
Consumption by Region
North America
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Radiopharmaceutical Injector manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Radiopharmaceutical Injector in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Radiopharmaceutical Injector Market Overview
1.1 Product Overview and Scope of Radiopharmaceutical Injector
1.2 Radiopharmaceutical Injector Segment by Type
1.2.1 Global Radiopharmaceutical Injector Market Value Comparison by Type (2024-2030)
1.2.2 PET Radioactive Drugs Injector
1.2.3 PET and SPECT Radioactive Drugs Injector
1.3 Radiopharmaceutical Injector Segment by Application
1.3.1 Global Radiopharmaceutical Injector Market Value by Application: (2024-2030)
1.3.2 Hospitals and Clinics
1.3.3 R&D Institution
1.4 Global Radiopharmaceutical Injector Market Size Estimates and Forecasts
1.4.1 Global Radiopharmaceutical Injector Revenue 2019-2030
1.4.2 Global Radiopharmaceutical Injector Sales 2019-2030
1.4.3 Global Radiopharmaceutical Injector Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Radiopharmaceutical Injector Market Competition by Manufacturers
2.1 Global Radiopharmaceutical Injector Sales Market Share by Manufacturers (2019-2024)
2.2 Global Radiopharmaceutical Injector Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Radiopharmaceutical Injector Average Price by Manufacturers (2019-2024)
2.4 Global Radiopharmaceutical Injector Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Radiopharmaceutical Injector, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Radiopharmaceutical Injector, Product Type & Application
2.7 Radiopharmaceutical Injector Market Competitive Situation and Trends
2.7.1 Radiopharmaceutical Injector Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Radiopharmaceutical Injector Players Market Share by Revenue
2.7.3 Global Radiopharmaceutical Injector Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Radiopharmaceutical Injector Retrospective Market Scenario by Region
3.1 Global Radiopharmaceutical Injector Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Radiopharmaceutical Injector Global Radiopharmaceutical Injector Sales by Region: 2019-2030
3.2.1 Global Radiopharmaceutical Injector Sales by Region: 2019-2024
3.2.2 Global Radiopharmaceutical Injector Sales by Region: 2025-2030
3.3 Global Radiopharmaceutical Injector Global Radiopharmaceutical Injector Revenue by Region: 2019-2030
3.3.1 Global Radiopharmaceutical Injector Revenue by Region: 2019-2024
3.3.2 Global Radiopharmaceutical Injector Revenue by Region: 2025-2030
3.4 North America Radiopharmaceutical Injector Market Facts & Figures by Country
3.4.1 North America Radiopharmaceutical Injector Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Radiopharmaceutical Injector Sales by Country (2019-2030)
3.4.3 North America Radiopharmaceutical Injector Revenue by Country (2019-2030)
3.4.4 Canada
3.5 Europe Radiopharmaceutical Injector Market Facts & Figures by Country
3.5.1 Europe Radiopharmaceutical Injector Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Radiopharmaceutical Injector Sales by Country (2019-2030)
3.5.3 Europe Radiopharmaceutical Injector Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Radiopharmaceutical Injector Market Facts & Figures by Country
3.6.1 Asia Pacific Radiopharmaceutical Injector Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Radiopharmaceutical Injector Sales by Country (2019-2030)
3.6.3 Asia Pacific Radiopharmaceutical Injector Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Radiopharmaceutical Injector Market Facts & Figures by Country
3.7.1 Latin America Radiopharmaceutical Injector Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Radiopharmaceutical Injector Sales by Country (2019-2030)
3.7.3 Latin America Radiopharmaceutical Injector Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Radiopharmaceutical Injector Market Facts & Figures by Country
3.8.1 Middle East and Africa Radiopharmaceutical Injector Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Radiopharmaceutical Injector Sales by Country (2019-2030)
3.8.3 Middle East and Africa Radiopharmaceutical Injector Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Radiopharmaceutical Injector Sales by Type (2019-2030)
4.1.1 Global Radiopharmaceutical Injector Sales by Type (2019-2024)
4.1.2 Global Radiopharmaceutical Injector Sales by Type (2025-2030)
4.1.3 Global Radiopharmaceutical Injector Sales Market Share by Type (2019-2030)
4.2 Global Radiopharmaceutical Injector Revenue by Type (2019-2030)
4.2.1 Global Radiopharmaceutical Injector Revenue by Type (2019-2024)
4.2.2 Global Radiopharmaceutical Injector Revenue by Type (2025-2030)
4.2.3 Global Radiopharmaceutical Injector Revenue Market Share by Type (2019-2030)
4.3 Global Radiopharmaceutical Injector Price by Type (2019-2030)
5 Segment by Application
5.1 Global Radiopharmaceutical Injector Sales by Application (2019-2030)
5.1.1 Global Radiopharmaceutical Injector Sales by Application (2019-2024)
5.1.2 Global Radiopharmaceutical Injector Sales by Application (2025-2030)
5.1.3 Global Radiopharmaceutical Injector Sales Market Share by Application (2019-2030)
5.2 Global Radiopharmaceutical Injector Revenue by Application (2019-2030)
5.2.1 Global Radiopharmaceutical Injector Revenue by Application (2019-2024)
5.2.2 Global Radiopharmaceutical Injector Revenue by Application (2025-2030)
5.2.3 Global Radiopharmaceutical Injector Revenue Market Share by Application (2019-2030)
5.3 Global Radiopharmaceutical Injector Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Medrad, Inc.(Bayer)
6.1.1 Medrad, Inc.(Bayer) Corporation Information
6.1.2 Medrad, Inc.(Bayer) Description and Business Overview
6.1.3 Medrad, Inc.(Bayer) Radiopharmaceutical Injector Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Medrad, Inc.(Bayer) Radiopharmaceutical Injector Product Portfolio
6.1.5 Medrad, Inc.(Bayer) Recent Developments/Updates
6.2 UNIVERSAL GIKEN
6.2.1 UNIVERSAL GIKEN Corporation Information
6.2.2 UNIVERSAL GIKEN Description and Business Overview
6.2.3 UNIVERSAL GIKEN Radiopharmaceutical Injector Sales, Revenue and Gross Margin (2019-2024)
6.2.4 UNIVERSAL GIKEN Radiopharmaceutical Injector Product Portfolio
6.2.5 UNIVERSAL GIKEN Recent Developments/Updates
6.3 Comecer
6.3.1 Comecer Corporation Information
6.3.2 Comecer Description and Business Overview
6.3.3 Comecer Radiopharmaceutical Injector Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Comecer Radiopharmaceutical Injector Product Portfolio
6.3.5 Comecer Recent Developments/Updates
6.4 Sumitomo Heavy Industries
6.4.1 Sumitomo Heavy Industries Corporation Information
6.4.2 Sumitomo Heavy Industries Description and Business Overview
6.4.3 Sumitomo Heavy Industries Radiopharmaceutical Injector Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sumitomo Heavy Industries Radiopharmaceutical Injector Product Portfolio
6.4.5 Sumitomo Heavy Industries Recent Developments/Updates
6.5 Tema Sinergie
6.5.1 Tema Sinergie Corporation Information
6.5.2 Tema Sinergie Description and Business Overview
6.5.3 Tema Sinergie Radiopharmaceutical Injector Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Tema Sinergie Radiopharmaceutical Injector Product Portfolio
6.5.5 Tema Sinergie Recent Developments/Updates
6.6 Lemer Pax
6.6.1 Lemer Pax Corporation Information
6.6.2 Lemer Pax Description and Business Overview
6.6.3 Lemer Pax Radiopharmaceutical Injector Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Lemer Pax Radiopharmaceutical Injector Product Portfolio
6.6.5 Lemer Pax Recent Developments/Updates
6.7 BQSV
6.6.1 BQSV Corporation Information
6.6.2 BQSV Description and Business Overview
6.6.3 BQSV Radiopharmaceutical Injector Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BQSV Radiopharmaceutical Injector Product Portfolio
6.7.5 BQSV Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Radiopharmaceutical Injector Industry Chain Analysis
7.2 Radiopharmaceutical Injector Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Radiopharmaceutical Injector Production Mode & Process
7.4 Radiopharmaceutical Injector Sales and Marketing
7.4.1 Radiopharmaceutical Injector Sales Channels
7.4.2 Radiopharmaceutical Injector Distributors
7.5 Radiopharmaceutical Injector Customers
8 Radiopharmaceutical Injector Market Dynamics
8.1 Radiopharmaceutical Injector Industry Trends
8.2 Radiopharmaceutical Injector Market Drivers
8.3 Radiopharmaceutical Injector Market Challenges
8.4 Radiopharmaceutical Injector Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
